CoChat

Immunologic aspect of ovarian cancer and p53 as tumor antigen

Open access
Nijman, HW, Lambeck, A, van der Burg, SH, van der Zee, AGJ, Daemen, T · 2005 · Journal of Translational Medicine
Cited by 34

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Ovarian cancer represents the fifth leading cause of death from all cancers for women. During the last decades overall survival has improved due to the use of new chemotherapy schedules. Still, the majority of patients die of this disease. Research reveals that ovarian cancer patients exhibit significant immune responses against their tumor. In this review the knowledge obtained thus far on the interaction of ovarian cancer tumor cells and the immune system is discussed. Furthermore the role of p53 as tumor antigen and its potential role as target antigen in ovarian cancer is summarized. Based on the increased knowledge on the role of the immune system in ovarian cancer major improvements are to be expected of immunotherapy based treatment of this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/1479-5876-3-34

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 34

Metadata

Authors
Nijman, H., Lambeck, A., van der Burg, S., van der Zee, A., & Daemen, T.
Venue
Journal of Translational Medicine
Published
2005-09-15
Volume
3
Issue
1
Pages
34-34
ISSN
1479-5876 (ISSN-L)
OpenAlex
W2150057437
Cited by
34
References
4
FWCI
1.25
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Immunologic aspect of ovarian cancer and p53 as tumor antigen. https://app.cochat.ai/papers/10.1186/1479-5876-3-34
The paper
Nijman, H., Lambeck, A., van der Burg, S., van der Zee, A., & Daemen, T. (2005). Immunologic aspect of ovarian cancer and p53 as tumor antigen. Journal of Translational Medicine. https://doi.org/10.1186/1479-5876-3-34

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.